| Description | Nurulimab (BCD-145) is a humanized monoclonal antibody targeting cytotoxic T lymphocyte antigen-4 (anti-CTLA-4). It has potential applications in melanoma research [1]. |
| molecular weight | N/A |
| CAS | 2168561-20-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |